Published January 14, 2022 | Version v1
Dataset Restricted

Dataset related to the article: "Cyclooxygenase-2 Glycosylation Is Affected by Peroxynitrite in Endothelial Cells: Impact on Enzyme Activity and Degradation"

  • 1. Centro Cardiologico Monzino I.R.C.C.S.
  • 2. Dipartimento di Scienze Farmacologiche, Università degli Studi di Milano
  • 3. Department of Biochemistry and Molecular Genetics, American University of Beirut; INSERM-UMR1149, Université de Paris
  • 4. Dipartimento di Scienze Farmaceutiche, Università degli Studi di Milano

Description

This record containsraw data related to the article: "Cyclooxygenase-2 Glycosylation Is Affected by Peroxynitrite in Endothelial Cells: Impact on Enzyme Activity and Degradation"

Abstract: The exposure of human endothelial cells to 3-morpholinosydnonimine (SIN-1) induced the
expression of cyclooxygenase-2 (COX-2) in a dose- and time-dependent manner. Interestingly, after a
prolonged incubation (>8 h) several proteoforms were visualized by Western blot, corresponding
to different states of glycosylation of the protein. This effect was specific for SIN-1 that generates
peroxynitrite and it was not detected with other nitric oxide-donors. Metabolic labeling experiments
using 35S or cycloheximide suggested that the formation of hypoglycosylated COX-2 was dependent
on de novo synthesis of the protein rather than the deglycosylation of the native protein. Moreover,
SIN-1 reduced the activity of the hexokinase, the enzyme responsible for the first step of glycolysis.
The hypoglycosylated COX-2 induced by SIN-1 showed a reduced capacity to generate prostaglandins
and the activity was only partially recovered after immunoprecipitation. Finally, hypoglycosylated
COX-2 showed a more rapid rate of degradation compared to COX-2 induced by IL-1a and an
alteration in the localization with an accumulation mainly detected in the nuclear membrane. Our
results have important implication to understand the effect of peroxynitrite on COX-2 expression
and activity, and they may help to identify new pharmacological tools direct to increase COX-2
degradation or to inhibit its activity.

Notes

This work was supported by the Italian Ministry of Health, Rome, Italy. Ricerca Corrente RC 2019 MPP1A ID 2755301

Files

Restricted

The record is publicly accessible, but files are restricted. <a href="https://zenodo.org/account/settings/login?next=https://zenodo.org/records/5845429">Log in</a> to check if you have access.

Request access

If you would like to request access to these files, please fill out the form below.

You need to satisfy these conditions in order for this request to be accepted:

 Please write your request to direzione.scientifica@ccfm.it 

You are currently not logged in. Do you have an account? Log in here

Additional details

Related works

Is supplement to
Journal article: 10.3390/antiox10030496 (DOI)